Because of the pathogenic role of germline RET mutations and their correlation with phenotype, all cases of MTC, both those with a clear familial-positive history and those apparently sporadic, must be submitted to the RET genetic screening. This evidence concerns the gene RET and medullary thyroid gland carcinoma.